Diabetes tolerogenic vaccines targeting antigen-specific inflammation

Shuang Geng(Shanghai Medical College of Fudan University), Bin Wang(Shanghai Medical College of Fudan University), Qingling Yu(Beijing VDJBio (China)), Douglas B. Lowrie(Fudan University), Xiaoping Xie(Shantou University), Yiwei Zhong(Shanghai Medical College of Fudan University), Yue He(Affiliated Hospital of Southwest Medical University), Xiaoqian Zhang, Chaofan Li(Carter Center), Huiyuan Zhang(Chengdu University of Technology), Zhonghuai He(Beijing VDJBio (China)), Guoxing Zheng(University of Illinois Chicago, Rockford campus), Xian Zhou(Western Sydney University)
Human Vaccines & Immunotherapeutics
January 26, 2015
10.1080/21645515.2014.1004024
Cited by 6

Related Papers

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
|Science Immunology|2022|366
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults
|JAMA Dermatology|2022|265
Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis
|Journal of Antimicrobial Chemotherapy|2019|239
The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells
|Immunity|2018|203
Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function
|Immunity|2022|174